Impingement syndrome refers to compression or pinching of the tendons or bursa between the acromion and humeral head during arm movements. This syndrome leads to shoulder pain and tenderness. The impingement syndrome treatments aim to reduce inflammation, manage pain and restore mobility. Some of the treatment options include medication, physiotherapy, corticosteroid injections and surgery.

Market key trends:

The growing geriatric population globally is one of the major factors driving the growth of the impingement syndrome market. As per the United Nations Population Fund data, by 2050 around 16.7% of the world's population will be over 65 years of age. With age, wear and tear of tendons and cartilage in shoulders increases the risk of developing impingement syndrome. Additionally, prevalence of sedentary lifestyles has increased the incidences of poor posture and lack of shoulder mobility leading to impingement syndrome. Furthermore, development of advanced arthroscopic techniques for impingement syndrome treatment over open surgeries is gaining popularity due to benefits like lesser complications, scars and faster recovery. This is expected to support the market growth during the forecast period.

Porter's Analysis

Threat of new entrants: The Impingement Syndrome Market Size requires high initial investments for R&D which poses a barrier for new players. Bargaining power of buyers: The presence of several treatment options gives high bargaining power to buyers to negotiate on prices. Bargaining power of suppliers: Established medical device manufacturers are the major suppliers with specialized product portfolio limiting the bargaining power of suppliers. Threat of new substitutes: Alternate non-surgical treatments provide limited threat due to invasiveness and long-term effectiveness of surgical procedures. Competitive rivalry: The market is fairly consolidated with key players differentiating based on portfolio breadth and depth intensifying competition.

SWOT Analysis

Strengths: Availability of minimally invasive surgical procedures reducing recovery time and complications. Weaknesses: High cost of surgical treatment and lack of awareness in developing regions about early diagnosis and management. Opportunities: Rising geriatric population suffering from joint disorders and growing healthcare expenditure boosting market growth. Threats: Risk of implant failure and revision surgeries; reimbursement issues related to new and costly treatments.

Read Our More Blogs : https://www.feedsfloor.com/pharmaceuticals/impingement-syndrome-market-estimated-witness-high-growth-owing-increasing